Control Bionics Inc has a Sales Consultant Opportunity open! The position is remote based out of either NC, TN or VA. Living in North Carolina is ideal! Apply here: https://lnkd.in/gHADWaFz
Control Bionics (ASX:CBL)
医疗设备
Camberwell，Victoria 1,861 位关注者
AAC Solutions | Make a Life-Changing Connection
关于我们
Control Bionics offers a suite of dedicated speech generating devices and AAC accessories to give people living with complex communication and physical needs their voice. Our product range is more intuitive and flexible than ever, giving users the power to make life-changing connections. Control Bionics makes NeuroNode, a sixth generation computer-human-interface (CHI) system that is designed to enable people with severe disabilities to communicate with their loved ones, carers, friends and the world at large with text, text-to-speech (TTS), instant messaging (IM), emails and the internet; and to control their own entertainment media (music, videos and online services) as well as expanding their own creativity with word processing, music and video editing, and design programs.
- 网站
-
https://www.controlbionics.com
Control Bionics (ASX:CBL)的外部链接
- 所属行业
- 医疗设备
- 规模
- 11-50 人
- 总部
- Camberwell，Victoria
- 类型
- 上市公司
- 创立
- 2006
地点
Control Bionics (ASX:CBL)员工
-
Kristin Whitfield
Learning and Development Professional | Augmentative Communication Specialist | Speech-Language Pathologist
-
Belva Holman
Regional Consultant at Control Bionics
-
Keith Jackson
Assistive Technology AAC Consultant with over 20 years experience
-
Jeffrey Kitchen
Director / Product Manager / Product Owner (ACSPO) / CSM / Project Manager
动态
-
Please come by and visit the team Friday to see #DROVE in action!
Exciting day at the Australian Assistive Technology Conference on the Gold Coast! We’re showcasing DROVE—the world’s first autonomous wheelchair module—and sharing our journey with this groundbreaking innovation. DROVE is all about empowering independence and redefining mobility for those who need it. Standing here with our team, seeing DROVE in action, reminds us why we do what we do: to make a real difference in people’s lives. Proud to bring this innovation forward with such an incredible team by my side. DROVE - Case Study https://lnkd.in/g49W8vwC Control Bionics (ASX:CBL) Lester Lo Jack Appleton-Seymour Jeremy Steele #AssistiveTechnology #ControlBionics #DROVE
-
-
Happy Occupational Therapist Week! ?? Here’s to all the amazing Occupational Therapists empowering lives through care, creativity, and compassion. ?? Thanks for everything you do ?? #OTWeek #OccupationalTherapy
-
-
ATIA’s October 30 webinar unpacks new federal guidance helping to expand access to assistive technology (AT) for children with disabilities. Speakers will share strategies for leveraging this guidance in your work. Register for free at atia.org/webinar
Path LMS
https://www.atia.org
-
Join us for an interactive event co-hosted by Control Bionics and a panel of experienced speech pathologists working within the NDIS space. Date: 13th of November 2024 at 6-8pm Location: Rooftop at 8 Adolph Street, Cremorne, VIC, 3121 Reserve your spot here: https://lnkd.in/gc7jxybC
-
-
Work closely with experienced Occupational Therapists from Better Rehab in an 8 week, part-time research project to assess the world's first autonomous wheelchair module, DROVE. If you would like to learn more, please reach out at [email protected].
-
-
Control Bionics boosts revenue with faster NDIS approvals and new leasing program https://buff.ly/47T9rZA #ASX #ASX200 $CBL Control Bionics (ASX:CBL)
Control Bionics boosts revenue with faster NDIS approvals and new leasing program - Stockhead
https://stockhead.com.au
-
We're thrilled to announce a significant increase in revenue thanks to faster NDIS approvals. With $1m in the pipeline, we are confident of continued success with the NDIS after securing ~$400k in approvals over the past 8 weeks. This is more than the previous five months combined. ?? New Launch - Long-term Leasing Program This initiative is for our Trilogy system in Australia, helping those with neurodegenerative conditions access life-changing communication technology faster with a more affordable option. First approvals are in, and we’re excited to roll out this initiative further with our NeuroNode product. ?? Rights Issue Update We're conducting a pro-rata non-renounceable rights issue to raise up to $2.1 million. The rights issue is underwritten for ~$890,000 and will support the commercialisation of the NeuroStrip, the launch of DROVE, and the expansion of the NeuroNode Only strategy. ?? Research and Development Tax Incentive We also recently received a Research and Development Tax Incentive of $736,794 for FY24. The debt facility with Radium Capital has now been repaid leaving a residual amount of $288,587. #NDIS #AssistiveTechnology #Neurotech #ControlBionics #ASXnews #Investment #NeuroNode Jeremy Steele Roger Hawke Joe Durak David Falk Kanak Sahasrabudhe Adi Deshpande
-
I enjoyed sitting down with Paul Sanger and the team at Finance News Network this week to discuss the strong six months Control Bionics (ASX:CBL) has had. We had the chance to talk about our recent success in the US and Europe and the outlook for FY25. We're looking forward to sharing further news in the coming months. https://lnkd.in/gY4VM_fX
From Stephen Hawking to basketball jump clinics: Control Bionics on the promise of EMG technology
finnewsnetwork.com.au
-
Thanks for the coverage Stockhead! Jeremy Steele David Falk Lindsay Phillips Roger Hawke Joe Durak Kanak Sahasrabudhe Adi Deshpande
Control Bionics inks UK and Ireland distribution deal for NeuroNode https://buff.ly/4cYizND #ASX #ASX200 $CBL Control Bionics (ASX:CBL)
Control Bionics inks UK and Ireland distribution deal for NeuroNode - Stockhead
https://stockhead.com.au